Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.90M | -32.18M | -35.99M | -35.86M | -37.64M |
| Total Depreciation and Amortization | 1.11M | 1.20M | 1.28M | 1.33M | 1.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.82M | 1.35M | 1.73M | 3.17M | 4.35M |
| Change in Net Operating Assets | -3.17M | -1.53M | 488.70K | 1.95M | 2.75M |
| Cash from Operations | -29.14M | -31.17M | -32.49M | -29.41M | -29.16M |
| Capital Expenditure | -700.10K | -641.10K | -740.40K | -437.90K | -748.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.97M | 27.51M | 29.60M | 8.19M | 17.82M |
| Cash from Investing | 26.27M | 26.87M | 28.86M | 7.76M | 17.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.81M | 4.95M | 887.60K | 458.60K | 103.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.81M | 4.95M | 887.60K | 458.60K | 103.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.95M | 646.30K | -2.74M | -21.20M | -11.98M |